-
1
-
-
33645097999
-
Clozapine-induced sialorrhea: Pathophysiology and management strategies
-
Praharaj SK, Arora M, Gandotra S. Clozapine-induced sialorrhea: pathophysiology and management strategies. Psychopharmacol (Berl). 2006;185:265-273.
-
(2006)
Psychopharmacol (Berl)
, vol.185
, pp. 265-273
-
-
Praharaj, S.K.1
Arora, M.2
Gandotra, S.3
-
2
-
-
12344296884
-
Sialorrhea: A review of a vexing, often unrecognized sign of oropharyngeal and esophageal disease
-
Boyce HW, Bakheet MR. Sialorrhea: a review of a vexing, often unrecognized sign of oropharyngeal and esophageal disease. J Clin Gastroenterol. 2005;39:89-97. (Pubitemid 40130019)
-
(2005)
Journal of Clinical Gastroenterology
, vol.39
, Issue.2
, pp. 89-97
-
-
Boyce, H.W.1
Bakheet, M.R.2
-
3
-
-
34347231321
-
Clozapine-induced hypersalivation: A review of treatment strategies
-
Sockalingam S, Shammi C, Remington G. Clozapine-induced hypersalivation: a review of treatment strategies. Can J Psychiatry. 2007;52:377-384. (Pubitemid 46997312)
-
(2007)
Canadian Journal of Psychiatry
, vol.52
, Issue.6
, pp. 377-384
-
-
Sockalingam, S.1
Shammi, C.2
Remington, G.3
-
4
-
-
0036139140
-
Clinical study of botulinum-A toxin in the treatment of sialorrhea in children with cerebral palsy
-
Suskind DL, Tilton A. Clinical study of Botulinum-A toxin in the treatment of sialorrhea with children with cerebral palsy. Laryngoscope. 2002;112:73-81. (Pubitemid 34037741)
-
(2002)
Laryngoscope
, vol.112
, Issue.1
, pp. 73-81
-
-
Suskind, D.L.1
Tilton, A.2
-
5
-
-
0038422869
-
Double-blind, placebo-controlled study to evaluate the efficacy and safety of botulinum toxin type A in the treatment of drooling Parkinsonism
-
DOI 10.1002/mds.10420
-
Mancini F, Zangaglia R, Cristina S, et al. Double-blind, placebo-controlled study to evaluate the efficacy and safety of botulinum toxin type A in the treatment of drooling in parkinsonism. Mov Disord. 2003;18:685-688. (Pubitemid 36790285)
-
(2003)
Movement Disorders
, vol.18
, Issue.6
, pp. 685-688
-
-
Mancini, F.1
Zangaglia, R.2
Cristina, S.3
Sommaruga, M.G.4
Martignoni, E.5
Nappi, G.6
Pacchetti, C.7
-
6
-
-
79953035523
-
Anticholinergics and amantadine
-
Sadock BJ, Sadock VA, Riuz P, eds. Philadelphia: Lippincott, Williams & Wilkins
-
Ahmad S. Anticholinergics and amantadine. In: Sadock BJ, Sadock VA, Riuz P, eds. Comprehensive Textbook of Psychiatry, Ninth ed. Philadelphia: Lippincott, Williams & Wilkins; 2009:3014-3020.
-
(2009)
Comprehensive Textbook of Psychiatry, Ninth Ed.
, pp. 3014-3020
-
-
Ahmad, S.1
-
7
-
-
0026033504
-
Antagonist binding profiles of five cloned human muscarinic receptor subtypes
-
Dörje F, Wess J, Lambrecht G, et al. Antagonist binding profiles of five cloned human muscarinic receptor subtypes. J Pharmacol Exp Ther. 1991;256:727-733.
-
(1991)
J Pharmacol Exp Ther
, vol.256
, pp. 727-733
-
-
Dörje, F.1
Wess, J.2
Lambrecht, G.3
-
8
-
-
0008006069
-
Trihexyphenidyl treatment of clozapine-induced hypersalivation
-
Spivak B, Adlersberg S, Rosen L, et al. Trihexyphenidyl treatment of clozapine-induced hypersalivation. J Clin Psychopharmacol. 1996;16:462-463.
-
(1996)
J Clin Psychopharmacol
, vol.16
, pp. 462-463
-
-
Spivak, B.1
Adlersberg, S.2
Rosen, L.3
-
9
-
-
0030801683
-
Trihexyphenidyl treatment of clozapine-induced hypersalivation
-
Spivak B, Adlersberg S, Rosen L, et al. Trihexyphenidyl treatment of clozapine-induced hypersalivation. Int Clin Psychopharmacol. 1997;12:213-215. (Pubitemid 27414635)
-
(1997)
International Clinical Psychopharmacology
, vol.12
, Issue.4
, pp. 213-215
-
-
Spivak, B.1
Adlersberg, S.2
Rosen, L.3
Gonen, N.4
Mester, R.5
Weizman, A.6
-
10
-
-
70450178470
-
Trihexyphenidyl (benzhexol) in clozapine-induced nocturnal enuresis and sialorrhea
-
Aggarwal A, Garg A, Jiloha RC. Trihexyphenidyl (benzhexol) in clozapine-induced nocturnal enuresis and sialorrhea. Indian J Med Sci. 2009;63:470-471.
-
(2009)
Indian J Med Sci
, vol.63
, pp. 470-471
-
-
Aggarwal, A.1
Garg, A.2
Jiloha, R.C.3
|